Synonyms: compound 38 [PMID: 36533617] | RMC5552
Compound class:
Synthetic organic
Comment: RMC-5552 is a selective bi-steric inhibitor of mTORC1 [1]. Mechanistically it interacts with both the orthosteric and allosteric binding sites of mTOR, and inhibits phosphorylation of S6K and 4EBP1 (to provide anti-tumour activity) whilst sparing mTORC2-mediated effects on AKT signalling and glucose metabolism. It was developed for potential to treat mTORC1-activated tumours, and is an active clinical lead (Jan 2023).
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Synonyms ![]() |
compound 38 [PMID: 36533617] | RMC5552 |
Database Links ![]() |
|
GtoPdb PubChem SID | 479821129 |
PubChem CID | 162640850 |
Search Google for chemical match using the InChIKey | IUTYTXDIGUNPAA-GKVGALOGSA-N |
Search Google for chemicals with the same backbone | IUTYTXDIGUNPAA |
UniChem Compound Search for chemical match using the InChIKey | IUTYTXDIGUNPAA-GKVGALOGSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | IUTYTXDIGUNPAA-GKVGALOGSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
RMC-5552 (links to external site)
Cat. No. HY-132168 |